Public Profile

DiaCarta, Inc.

DiaCarta, Inc., a leading biotechnology company headquartered in the United States, specialises in molecular diagnostics and personalised medicine. Founded in 2009, DiaCarta has made significant strides in the development of innovative diagnostic solutions, particularly in the fields of oncology and infectious diseases. The company is renowned for its proprietary technology, which includes advanced liquid biopsy tests that enable early cancer detection and monitoring. DiaCarta's unique approach combines precision and sensitivity, setting it apart in a competitive market. With a strong presence in North America and expanding operations in Asia, DiaCarta continues to solidify its position as a key player in the biotechnology industry, committed to improving patient outcomes through cutting-edge diagnostic tools.

DitchCarbon Score

How does DiaCarta, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

25

Industry Benchmark

DiaCarta, Inc.'s score of 23 is lower than 51% of the industry. This can give you a sense of how well the company is doing compared to its peers.

49%

DiaCarta, Inc.'s reported carbon emissions

DiaCarta, Inc., headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor specific reduction targets or initiatives outlined in their climate commitments. Without concrete emissions figures or defined reduction strategies, it is challenging to assess their current environmental impact or commitments to climate action. However, the absence of data does not preclude the possibility of ongoing efforts in sustainability and emissions reduction within the industry context. As a biotechnology company, DiaCarta may be engaged in practices aimed at minimising their carbon footprint, aligning with broader industry trends towards sustainability and climate responsibility.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. DiaCarta, Inc.'s primary industry is Research and development services (73), which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. DiaCarta, Inc. is headquartered in US, which has a rank of low, indicating low grid carbon intensity.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

DiaCarta, Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero

Was this information valuable to you?

Similar Organizations

Foundation Medicine, Inc.

US
Health and social work services (85)
Updated 2 months ago
DitchCarbon Score

Natera

US
Research and development services (73)
Updated about 1 month ago

Neogenomics

US
Other business services (74)
Updated 2 days ago

Epic Sciences, Inc.

US
Other business services (74)
Updated about 1 month ago

Tempus AI

US
Other business services (74)
Updated about 1 month ago

ANGLE plc

GB
Medical, precision and optical instruments, watches and clocks (33)
Updated about 1 month ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers